Home › Calculator › MRVI Dividend Calculator 2026
MRVI Dividend DRIP Calculator 2026
32.44% YieldHealthcareMaravai LifeSciences Holdings, Inc. · NASDAQ
Price: $6.17 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When MRVI pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your MRVI snowball 📈
$10,000 in MRVI → $40585496.63M in 10 years · $3,371,974,220,282.49/month
About Maravai LifeSciences Holdings, Inc. (MRVI) — Dividend Analysis 2026
Maravai LifeSciences Holdings, Inc. is a life sciences company operating globally, supplying essential products that facilitate the advancement of drug therapies, diagnostics, innovative vaccines, and research into human diseases. Its diverse product line supports critical stages of biopharmaceutical development, featuring nucleic acids for both diagnostic and therapeutic applications, antibody-based solutions for detecting impurities in biopharmaceutical manufacturing, and tools for monitoring protein expression across different tissue types. The company conducts its operations through two distinct segments: Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment specializes in manufacturing and distributing products integral to gene therapy, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics. This encompasses reagents utilized in the chemical synthesis, modification, labeling, and purification of DNA and RNA. Additionally, this division provides messenger RNA, oligonucleotides, their foundational building blocks, plasmid DNA, and the proprietary CleanCap capping technology. Meanwhile, the Biologics Safety Testing segment offers analytical products vital for developing biologic manufacturing processes. Its offerings include bespoke antibody and assay development services tailored to specific products, alongside HCP ELISA kits, various other ELISA kits for identifying bioprocess impurities and contaminants, ancillary reagents, and custom service solutions. Maravai's clientele spans biopharmaceutical companies, other life sciences and biopharmaceutical research firms, academic research institutions, and in vitro diagnostics companies. Incorporated in 2020, Maravai LifeSciences Holdings, Inc. maintains its headquarters in San Diego, California.
Compare MRVI with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full MRVI DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open MRVI position with:
🌍 MRVI Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold MRVI.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 32.44% | 29.64% | $3,244 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 27.57% | 24.77% | $2,757 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 25.95% | 23.15% | $2,595 / yr |
| 🇬🇧 UK ISA | 0% | 32.44% | 29.64% | $3,244 / yr |
| 🇬🇧 UK Taxable | 8.75% | 29.60% | 26.80% | $2,960 / yr |
| 🇨🇦 TFSA | 0% | 32.44% | 29.64% | $3,244 / yr |
| 🇨🇦 CA Taxable | 25% | 24.33% | 21.53% | $2,433 / yr |
| 🇦🇺 Super (pension) | 15% | 27.57% | 24.77% | $2,757 / yr |
| 🇦🇺 AU Taxable | 30% | 22.71% | 19.91% | $2,271 / yr |
| 🇩🇪 DE Taxable | 26.375% | 23.88% | 21.08% | $2,388 / yr |
| 🇫🇷 FR Taxable | 30% | 22.71% | 19.91% | $2,271 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 MRVI Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 MRVI Dividend Payment Schedule
MRVI pays quarterly — 4 times per year. Next ex-div: TBD.
📊 MRVI vs Healthcare Benchmarks
How MRVI compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for MRVI sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ MRVI Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| F-InKind | 2026-08-31 | 5,465 | $7.68 | $42.0K | ||
| F-InKind | 2026-08-10 | 29,250 | $6.23 | $182.2K | ||
| F-InKind | 2026-07-30 | 5,465 | $6.59 | $36.0K | ||
| F-InKind | 2026-07-08 | 29,250 | $5.92 | $173.2K | ||
| F-InKind | 2026-06-30 | 65,584 | $6.39 | $419.1K | ||
| F-InKind | 2026-06-08 | 351,001 | $5.02 | $1.76M | ||
| Sale | 2026-06-09 | 25,000 | $5.06 | $126.5K | ||
| Sale | 2026-06-10 | 25,000 | $5.10 | $127.5K | ||
| G-Gift | 2026-06-09 | 46,293 | — | — | ||
| G-Gift | 2026-06-09 | 46,293 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where MRVI earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the MRVI dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Maravai LifeSciences Holdings, Inc. (MRVI) is currently trading at $6.17, 89% below its 52-week high. The current dividend yield is 32.44% based on an annual payout of $2.00 per share.
MRVI (Maravai LifeSciences Holdings, Inc.) — 32.44% Dividend Yield Analysis
Maravai LifeSciences Holdings, Inc. (MRVI) is a healthcare stock currently trading at $6.17 with a dividend yield of 32.44%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (32.44%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest MRVI News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.